These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 24163786)

  • 1. Paclitaxel Nano-Delivery Systems: A Comprehensive Review.
    Ma P; Mumper RJ
    J Nanomed Nanotechnol; 2013 Feb; 4(2):1000164. PubMed ID: 24163786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano delivery system for paclitaxel: Recent advances in cancer theranostics.
    Ying N; Liu S; Zhang M; Cheng J; Luo L; Jiang J; Shi G; Wu S; Ji J; Su H; Pan H; Zeng D
    Colloids Surf B Biointerfaces; 2023 Aug; 228():113419. PubMed ID: 37393700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Novel Paclitaxel Nanoparticles Prepared by Laser Irradiation.
    Suzuki M; Takebe G; Takagi T; Tsukada H
    Chem Pharm Bull (Tokyo); 2022; 70(4):269-276. PubMed ID: 35370203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
    Kim SC; Kim DW; Shim YH; Bang JS; Oh HS; Wan Kim S; Seo MH
    J Control Release; 2001 May; 72(1-3):191-202. PubMed ID: 11389998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances of paclitaxel formulations based on nanosystem delivery technology.
    Luo C; Wang Y; Chen Q; Han X; Liu X; Sun J; He Z
    Mini Rev Med Chem; 2012 May; 12(5):434-44. PubMed ID: 22303950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel(TM).
    Madaan A; Singh P; Awasthi A; Verma R; Singh AT; Jaggi M; Mishra SK; Kulkarni S; Kulkarni H
    Clin Transl Oncol; 2013 Jan; 15(1):26-32. PubMed ID: 22855169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
    Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
    Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
    Feng SS; Mu L; Win KY; Huang G
    Curr Med Chem; 2004 Feb; 11(4):413-24. PubMed ID: 14965222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-based targeted drug delivery for lung cancer: therapeutic avenues and challenges.
    Ezhilarasan D; Lakshmi T; Mallineni SK
    Nanomedicine (Lond); 2022 Oct; 17(24):1855-1869. PubMed ID: 35311343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
    Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
    Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery.
    Varan G; Benito JM; Mellet CO; Bilensoy E
    Beilstein J Nanotechnol; 2017; 8():1457-1468. PubMed ID: 28900599
    [No Abstract]   [Full Text] [Related]  

  • 14. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers.
    Gawde KA; Sau S; Tatiparti K; Kashaw SK; Mehrmohammadi M; Azmi AS; Iyer AK
    Colloids Surf B Biointerfaces; 2018 Jul; 167():8-19. PubMed ID: 29625422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.
    Xiao K; Luo J; Fowler WL; Li Y; Lee JS; Xing L; Cheng RH; Wang L; Lam KS
    Biomaterials; 2009 Oct; 30(30):6006-16. PubMed ID: 19660809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current strategies for different paclitaxel-loaded Nano-delivery Systems towards therapeutic applications for ovarian carcinoma: A review article.
    Khalifa AM; Elsheikh MA; Khalifa AM; Elnaggar YSR
    J Control Release; 2019 Oct; 311-312():125-137. PubMed ID: 31476342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of serum proteins on drug delivery.
    Kratz F; Elsadek B
    J Control Release; 2012 Jul; 161(2):429-45. PubMed ID: 22155554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of oxidative stress by Taxol® vehicle Cremophor-EL triggers production of interleukin-8 by peripheral blood mononuclear cells through the mechanism not requiring de novo synthesis of mRNA.
    Ilinskaya AN; Clogston JD; McNeil SE; Dobrovolskaia MA
    Nanomedicine; 2015 Nov; 11(8):1925-38. PubMed ID: 26282378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, optimization, hemocompatibility and pharmacokinetic evaluation of PLGA nanoparticles containing paclitaxel.
    Mittal P; Vardhan H; Ajmal G; Bonde GV; Kapoor R; Mittal A; Mishra B
    Drug Dev Ind Pharm; 2019 Mar; 45(3):365-378. PubMed ID: 30394795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
    Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
    Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.